Published in AIDS Weekly, June 23rd, 1997
Merck has licensed naked DNA technology from Vical Inc., San Diego, California, for use in developing vaccines for HIV and six other pathogens (hepatitis B, hepatitis C, herpes simplex, human papilloma virus, influenza, and tuberculosis).
"Merck has already invested thousands of research hours and millions of dollars toward the discovery, development,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.